Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Arteriovenous fistula of superficial temporal vessels.
Biegaj E, Rutkowska-Zimirska J, Radzymińska-Maliszewska M, Zaremba A, Pniewski J. Biegaj E, et al. Among authors: zaremba a. Folia Morphol (Warsz). 2019;78(4):879-882. doi: 10.5603/FM.a2019.0016. Epub 2019 Feb 28. Folia Morphol (Warsz). 2019. PMID: 30816554 Free article.
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma.
Tarantino G, Ricker CA, Wang A, Ge W, Aprati TJ, Huang AY, Madha S, Chen J, Shi Y, Glettig M, Feng CH, Frederick DT, Freeman S, Holovatska MM, Manos MP, Zimmer L, Rösch A, Zaremba A, Livingstone E, Jameson JC, Saghafian S, Lee A, Zhao K, Morris LGT, Reardon B, Park J, Elmarakeby HA, Schilling B, Giobbie-Hurder A, Vokes NI, Buchbinder EI, Flaherty KT, Haq R, Wu CJ, Boland GM, Hodi FS, Van Allen EM, Schadendorf D, Liu D. Tarantino G, et al. Among authors: zaremba a. Sci Adv. 2024 Nov 29;10(48):eadp4670. doi: 10.1126/sciadv.adp4670. Epub 2024 Nov 27. Sci Adv. 2024. PMID: 39602539 Free PMC article.
Harnessing the power of AI in precision medicine: NGS-based therapeutic insights for colorectal cancer cohort.
Murcia Pienkowski V, Skoczylas P, Zaremba A, Kłęk S, Balawejder M, Biernat P, Czarnocka W, Gniewek O, Grochowalski Ł, Kamuda M, Król-Józaga B, Marczyńska-Grzelak J, Mazzocco G, Szatanek R, Widawski J, Welanyk J, Orzeszko Z, Szura M, Torbicz G, Borys M, Wohadlo Ł, Wysocki M, Karczewski M, Markowska B, Kucharczyk T, Piatek MJ, Jasiński M, Warchoł M, Kaczmarczyk J, Blum A, Sanecka-Duin A. Murcia Pienkowski V, et al. Among authors: zaremba a. Front Oncol. 2024 Oct 7;14:1407465. doi: 10.3389/fonc.2024.1407465. eCollection 2024. Front Oncol. 2024. PMID: 39435285 Free PMC article.
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas.
Jansen P, Galetzka W, Lodde GC, Standl F, Zaremba A, Herbst R, Terheyden P, Utikal J, Pföhler C, Ulrich J, Kreuter A, Mohr P, Gutzmer R, Meier F, Dippel E, Weichenthal M, Placke JM, Landsberg J, Möller I, Sucker A, Paschen A, Hadaschik E, Zimmer L, Livingstone E, Schadendorf D, Ugurel S, Stang A, Griewank KG. Jansen P, et al. Among authors: zaremba a. Eur J Cancer. 2024 Sep;208:114208. doi: 10.1016/j.ejca.2024.114208. Epub 2024 Jul 6. Eur J Cancer. 2024. PMID: 39018633 Free article.
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma.
Matull J, Placke JM, Lodde G, Zaremba A, Utikal J, Terheyden P, Pföhler C, Herbst R, Kreuter A, Welzel J, Kretz J, Möller I, Sucker A, Paschen A, Livingstone E, Zimmer L, Hadaschik E, Ugurel S, Schadendorf D, Thielmann CM, Griewank KG. Matull J, et al. Among authors: zaremba a. Front Immunol. 2024 Jun 5;15:1383125. doi: 10.3389/fimmu.2024.1383125. eCollection 2024. Front Immunol. 2024. PMID: 38903495 Free PMC article.
The resilience of Ukrainian scientists.
Piven O, Pokrytiuk V, Kasianchuk N, Ostash B, Dekina S, Panchuk R, Boldyriev O, Bashynska V, Zaremba A, Faidiuk Y, Obolenskaya MY, Polishchuk A, Petrenko O. Piven O, et al. Among authors: zaremba a. Cell Syst. 2024 Apr 17;15(4):298-304. doi: 10.1016/j.cels.2024.03.006. Cell Syst. 2024. PMID: 38636455
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma.
Albrecht LJ, Dimitriou F, Grover P, Hassel JC, Erdmann M, Forschner A, Johnson DB, Váraljai R, Lodde G, Placke JM, Krefting F, Zaremba A, Ugurel S, Roesch A, Schulz C, Berking C, Pöttgen C, Menzies AM, Long GV, Dummer R, Livingstone E, Schadendorf D, Zimmer L. Albrecht LJ, et al. Among authors: zaremba a. Eur J Cancer. 2024 May;202:113976. doi: 10.1016/j.ejca.2024.113976. Epub 2024 Mar 1. Eur J Cancer. 2024. PMID: 38484692 Free article.
142 results